Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.35 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | DPP7 | Q9UHL4 | 6/20 | 0.34 |
| ▸ | DPP4 | P27487 | 5/20 | 0.34 |
| ▸ | DPP8 | Q6V1X1 | 3/20 | 0.34 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL31327095 | 0.89 | KDM4E (0.37) | KDM4EALDH1A1HRH3ALOX15DPP7 | |
| Trifluoroacetic Acid SCHEMBL31327078 | 0.83 | CYP1A2 (0.36) | DPP7DPP4DPP8SIGMAR1 | |
| Trifluoroacetic Acid SCHEMBL31327108 | 0.83 | PRCP (0.35) | KDM4EALDH1A1DPP4DPP8KCNH2 | |
| Trifluoroacetic Acid SCHEMBL31327141 | 0.81 | HRH3 (0.40) | HRH3DPP7DPP4DPP8SIGMAR1 | |
| Trifluoroacetic Acid SCHEMBL1700238 | 0.80 | HRH3 (0.43) | HRH3 | |
| SCHEMBL31327023 | 0.80 | PHGDH (0.30) | HRH3 | |
| Trifluoroacetic Acid SCHEMBL31327037 | 0.79 | IRAK4 (0.36) | KDM4EALDH1A1HRH3ALOX15DPP7 | |
| Trifluoroacetic Acid SCHEMBL18225933 | 0.79 | KDM1A (0.40) | ALDH1A1HRH3DPP7DPP4DPP8 | |
| Trifluoroacetic Acid SCHEMBL21645222 | 0.78 | L3MBTL1 (0.39) | KDM4EALDH1A1HRH3DPP4DPP8 | |
| Trifluoroacetic Acid SCHEMBL1700180 | 0.78 | L3MBTL1 (0.39) | KDM4EALDH1A1HRH3DPP4DPP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250066383-A1 | PDE 7 MODULATOR COMPOUNDS | OMEROS CORPORATION | 2025-02-27 | — | — | US | disclosed |
| WO-2025042956-A1 | PDE 7 MODULATOR COMPOUNDS | OMEROS CORPORATION (US) | 2025-02-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250066383-A1 | PDE 7 MODULATOR COMPOUNDS | PDE7A, PDE3A, PDE3B | KDM4E 915/4885ALDH1A1 1479/4885HRH3 3843/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.